164 related articles for article (PubMed ID: 37791304)
1. Loss of YTHDF2 Alters the Expression of m
Golubeva VA; Dorn LE; Gilbert CJ; Rabolli CP; Das AS; Wanasinghe VS; Veress R; Terentyev D; Accornero F
JACC Basic Transl Sci; 2023 Sep; 8(9):1180-1194. PubMed ID: 37791304
[TBL] [Abstract][Full Text] [Related]
2. Ythdf2 regulates cardiac remodeling through its mRNA target transcripts.
Kmietczyk V; Oelschläger J; Gupta P; Varma E; Hartl S; Furkel J; Konstandin M; Marx A; Loewenthal Z; Kamuf-Schenk V; Jürgensen L; Stroh C; Gorska A; Martin-Garrido A; Heineke J; Jakobi T; Frey N; Völkers M
J Mol Cell Cardiol; 2023 Aug; 181():57-66. PubMed ID: 37315764
[TBL] [Abstract][Full Text] [Related]
3. A biallelic loss-of-function variant in MYZAP is associated with a recessive form of severe dilated cardiomyopathy.
Maver A; Zigman T; Rangrez AY; Coric M; Homolak J; Saric D; Skific I; Udovicic M; Zekusic M; Saleem U; Laufer SD; Hansen A; Frey N; Baric I; Peterlin B
Cold Spring Harb Mol Case Stud; 2022 Jul; 8(5):. PubMed ID: 35840178
[TBL] [Abstract][Full Text] [Related]
4. The lncRNA MIAT regulates CPT-1a mediated cardiac hypertrophy through m
Yang Y; Mbikyo MB; Zhang J; Zhang Y; Zhang N; Li Z
Cell Death Discov; 2022 Apr; 8(1):167. PubMed ID: 35383152
[TBL] [Abstract][Full Text] [Related]
5. YTHDF2 alleviates cardiac hypertrophy via regulating Myh7 mRNA decoy.
Xu H; Wang Z; Chen M; Zhao W; Tao T; Ma L; Ni Y; Li W
Cell Biosci; 2021 Jul; 11(1):132. PubMed ID: 34266473
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-145 Modulates
Yang Z; Li J; Feng G; Gao S; Wang Y; Zhang S; Liu Y; Ye L; Li Y; Zhang X
J Biol Chem; 2017 Mar; 292(9):3614-3623. PubMed ID: 28104805
[No Abstract] [Full Text] [Related]
7. The N
Dorn LE; Lasman L; Chen J; Xu X; Hund TJ; Medvedovic M; Hanna JH; van Berlo JH; Accornero F
Circulation; 2019 Jan; 139(4):533-545. PubMed ID: 30586742
[TBL] [Abstract][Full Text] [Related]
8. YTHDF2 Promotes Cardiac Ferroptosis
Pang P; Si W; Wu H; Ju J; Liu K; Wang C; Jia Y; Diao H; Zeng L; Jiang W; Yang Y; Xiong Y; Kong X; Zhang Z; Zhang F; Song J; Wang N; Yang B; Bian Y
Antioxid Redox Signal; 2023 Nov; ():. PubMed ID: 37548549
[No Abstract] [Full Text] [Related]
9. The RNA m
Ivanova I; Much C; Di Giacomo M; Azzi C; Morgan M; Moreira PN; Monahan J; Carrieri C; Enright AJ; O'Carroll D
Mol Cell; 2017 Sep; 67(6):1059-1067.e4. PubMed ID: 28867294
[TBL] [Abstract][Full Text] [Related]
10. Exercise training decreases lactylation and prevents myocardial ischemia-reperfusion injury by inhibiting YTHDF2.
Xu GE; Yu P; Hu Y; Wan W; Shen K; Cui X; Wang J; Wang T; Cui C; Chatterjee E; Li G; Cretoiu D; Sluijter JPG; Xu J; Wang L; Xiao J
Basic Res Cardiol; 2024 Apr; ():. PubMed ID: 38563985
[TBL] [Abstract][Full Text] [Related]
11. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
[TBL] [Abstract][Full Text] [Related]
12. Ythdf2-mediated m
Li M; Zhao X; Wang W; Shi H; Pan Q; Lu Z; Perez SP; Suganthan R; He C; Bjørås M; Klungland A
Genome Biol; 2018 May; 19(1):69. PubMed ID: 29855337
[TBL] [Abstract][Full Text] [Related]
13. YTHDF2 Binds to 5-Methylcytosine in RNA and Modulates the Maturation of Ribosomal RNA.
Dai X; Gonzalez G; Li L; Li J; You C; Miao W; Hu J; Fu L; Zhao Y; Li R; Li L; Chen X; Xu Y; Gu W; Wang Y
Anal Chem; 2020 Jan; 92(1):1346-1354. PubMed ID: 31815440
[TBL] [Abstract][Full Text] [Related]
14. YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation.
Zhang C; Huang S; Zhuang H; Ruan S; Zhou Z; Huang K; Ji F; Ma Z; Hou B; He X
Oncogene; 2020 Jun; 39(23):4507-4518. PubMed ID: 32366907
[TBL] [Abstract][Full Text] [Related]
15. Ythdf2 promotes pulmonary hypertension by suppressing Hmox1-dependent anti-inflammatory and antioxidant function in alveolar macrophages.
Hu L; Yu Y; Shen Y; Huang H; Lin D; Wang K; Yu Y; Li K; Cao Y; Wang Q; Sun X; Qiu Z; Wei D; Shen B; Chen J; Fulton D; Ji Y; Wang J; Chen F
Redox Biol; 2023 May; 61():102638. PubMed ID: 36801705
[TBL] [Abstract][Full Text] [Related]
16. YTHDF2 Recognition of N
Seo KW; Kleiner RE
ACS Chem Biol; 2020 Jan; 15(1):132-139. PubMed ID: 31815430
[TBL] [Abstract][Full Text] [Related]
17. Mettl3-mediated m
Jiang FQ; Liu K; Chen JX; Cao Y; Chen WY; Zhao WL; Song GH; Liang CQ; Zhou YM; Huang HL; Huang RJ; Zhao H; Park KS; Ju Z; Cai D; Qi XF
Elife; 2022 Nov; 11():. PubMed ID: 36399125
[TBL] [Abstract][Full Text] [Related]
18. YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated m
Chai RC; Chang YZ; Chang X; Pang B; An SY; Zhang KN; Chang YH; Jiang T; Wang YZ
J Hematol Oncol; 2021 Jul; 14(1):109. PubMed ID: 34246306
[TBL] [Abstract][Full Text] [Related]
19. YTHDF2 destabilizes m
Heck AM; Russo J; Wilusz J; Nishimura EO; Wilusz CJ
RNA; 2020 Jun; 26(6):739-755. PubMed ID: 32169943
[No Abstract] [Full Text] [Related]
20. FBW7 suppresses ovarian cancer development by targeting the N
Xu F; Li J; Ni M; Cheng J; Zhao H; Wang S; Zhou X; Wu X
Mol Cancer; 2021 Mar; 20(1):45. PubMed ID: 33658012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
